FIB-4 and APRI for cirrhosis detection in a privately insured national cohort
JHEP Reports · 2024-01 · 6 (1) · 100925
DOI: 10.1016/j.jhepr.2023.100925 ↗Kurz gefasst
Fachartikel in der Zeitschrift JHEP Reports, 2024-01. Verfasst von Neehar D Parikh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology and Hepatology, University of Michigan, USA. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Background and Aims: Non-invasive laboratory-based fibrosis indices have been proposed as a tool for population-based screening for advanced fibrosis. We aimed to examine the performance of fibrosis indices at the time of and prior to cirrhosis diagnosis. Methods: We included adult patients with cirrhosis diagnosis codes in a privately insured database (Optum) from 2010-2018 with 1:4 birth year-matched controls without cirrhosis diagnosis codes. We analyzed aspartate aminotransferase-to-platelet ratio index (APRI), and fibrosis-4 index (FIB-4) up to 30 months prior to the entry of cirrhosis diagnosis codes. Cut-offs of
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Gastroenterology and Hepatology, University of Michigan, USA.
Förderung
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Parikh, N. D., Mehta, M., & Tapper, E. B. (2024). FIB-4 and APRI for cirrhosis detection in a privately insured national cohort. JHEP Reports, 6(1), 100925. https://doi.org/10.1016/j.jhepr.2023.100925
Vancouver
Parikh ND, Mehta M, Tapper EB. FIB-4 and APRI for cirrhosis detection in a privately insured national cohort. JHEP Reports. 2024;6(1):100925. doi:10.1016/j.jhepr.2023.100925
BibTeX
@article{Parikh2024,
author = {Parikh, Neehar D and Mehta, Manaav and Tapper, Elliot B},
title = {FIB-4 and APRI for cirrhosis detection in a privately insured national cohort},
journal = {JHEP Reports},
year = {2024},
volume = {6},
number = {1},
pages = {100925},
doi = {10.1016/j.jhepr.2023.100925}
}
EUVIMED